takeyori saheki

Dr. takeyori saheki

Department of HYgiene and Health Promotion Medicine, Kagoshima University graduate School of Medical and Dental Sciences

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2011 in Journal of Neuroscience Research
Verified
Journal Article
Open access
PDF file
MRMilagros Ramos
Milagros Ramos
Beatriz PardoBeatriz Pardo
Beatriz Pardo
ILIrene Llorente‐Folch
Irene Llorente‐Folch
TStakeyori saheki
takeyori saheki
AAAraceli del Arco
Araceli del Arco
JSJorgina Satrustegui
Jorgina Satrustegui
The aralar/AGC1 knockout (KO) mouse shows a drastic decrease in brain aspartate and N‐acetylaspartate levels and global hypomyelination, which are attributed to the lack of neuron‐produced NAA used by oligodendrocytes as precursor of myelin lipid synthesis. In addition, these mice have a gradual drop in brain glutamine synthesis. We show here that hypomyelination is more pronounced in gray than in white matter regions. We find a lack of neurofilament‐labelled processes in hypomyelinated fiber tracks from cerebral cortex but not from those of the cerebellar granule cell layer, which correspond to Purkinje neurons. Therefore, the impaired development or degeneration of neuronal processes in cerebral cortex is independent of hypomyelination. An increase in O4‐labelled, immature oligodendrocytes is observed in gray and white matter regions of the aralar KO brain, suggesting a block in maturation compatible with the lack of NAA supplied by neurons. However, no defects in oligodendrocyte maturation were observed in in‐vitro‐cultured mixed astroglial cultures. We conclude that the primary defect of pyramidal neurons in cerebral cortex is possibly associated with a progressive failure in glutamatergic neurotransmission and may be among the main causes of the pathology of aralar/AGC1 deficiency.

24 July 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
TStakeyori saheki
takeyori saheki
MMMitsuaki Moriyama
Mitsuaki Moriyama
AFAki Funahashi
Aki Funahashi
EKEishi Kuroda
Eishi Kuroda
Can you imagine a disease in which intake of an excess amount of sugars or carbohydrates causes hyperammonemia? It is hard to imagine the intake causing hyperammonemia. AGC2 or citrin deficiency shows their symptoms following sugar/carbohydrates intake excess and this disease is now known as a pan-ethnic disease. AGC2 (aspartate glutamate carrier 2) or citrin is a mitochondrial transporter which transports aspartate (Asp) from mitochondria to cytosol in exchange with glutamate (Glu) and H+. Asp is originally supplied from mitochondria to cytosol where it is necessary for synthesis of proteins, nucleotides, and urea. In cytosol, Asp can be synthesized from oxaloacetate and Glu by cytosolic Asp aminotransferase, but oxaloacetate formation is limited by the amount of NAD+. This means an increase in NADH causes suppression of Asp formation in the cytosol. Metabolism of carbohydrates and other substances which produce cytosolic NADH such as alcohol and glycerol suppress oxaloacetate formation. It is forced under citrin deficiency since citrin is a member of malate/Asp shuttle. In this review, we will describe history of identification of the SLC25A13 gene as the causative gene for adult-onset type II citrullinemia (CTLN2), a type of citrin deficiency, pathophysiology of citrin deficiency together with animal models and possible treatments for citrin deficiency newly developing.

1 August 2001 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
TATsutomu Aoshima
Tsutomu Aoshima
MKMitsuharu Kajita
Mitsuharu Kajita
YSYoshitaka Sekido
Yoshitaka Sekido
SMShunji Mimura
Shunji Mimura
AIAtsuo Itakura
Atsuo Itakura
TNToshimitsu Niwa
Toshimitsu Niwa

1 September 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
MMMitsuaki Moriyama
Mitsuaki Moriyama
YFYuki Fujimoto
Yuki Fujimoto
SRShizuka Rikimaru
Shizuka Rikimaru
MUMiharu Ushikai
Miharu Ushikai
EKEishi Kuroda
Eishi Kuroda
TStakeyori saheki
takeyori saheki

1 November 2004 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
SIShun Ito
Shun Ito
GKGotaro Kurasawa
Gotaro Kurasawa
KYKyoko Yamamoto
Kyoko Yamamoto
IFIzumi Furuta
Izumi Furuta
FIFumitake Ishihara
Fumitake Ishihara
HKHiroshige Kakinoki
Hiroshige Kakinoki

12 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TStakeyori saheki
takeyori saheki
MMMitsuaki Moriyama
Mitsuaki Moriyama
EKEishi Kuroda
Eishi Kuroda
AFAki Funahashi
Aki Funahashi
IYIzumi Yasuda
Izumi Yasuda
YTYen How Tai
Yen How Tai
Previous studies using citrin/mitochondrial glycerol-3-phosphate (G3P) dehydrogenase (mGPD) double-knockout mice have demonstrated that increased dietary protein reduces the extent of carbohydrate-induced hyperammonemia observed in these mice. This study aimed to further elucidate the mechanisms of this effect. Specific amino acids were initially found to decrease hepatic G3P, or increase aspartate or citrulline levels, in mGPD-knockout mice administered ethanol. Unexpectedly, oral glycine increased ammonia in addition to lowering G3P and increasing citrulline. Subsequently, simultaneous glycine-plus-sucrose (Gly + Suc) administration led to a more severe hyperammonemic state in double-KO mice compared to sucrose alone. Oral arginine, ornithine, aspartate, alanine, glutamate and medium-chain triglycerides all lowered blood ammonia following Gly + Suc administration, with combinations of ornithine-plus-aspartate (Orn + Asp) or ornithine-plus-alanine (Orn + Ala) suppressing levels similar to wild-type. Liver perfusion and portal vein-arterial amino acid differences suggest that oral aspartate, similar to alanine, likely activated ureagenesis from ammonia and lowered the cytosolic NADH/NAD+ ratio through conversion to alanine in the small intestine. In conclusion, Gly + Suc administration induces a more severe hyperammonemic state in double-KO mice that Orn + Asp or Orn + Ala both effectively suppress. Aspartate-to-alanine conversion in the small intestine allows for effective oral administration of either, demonstrating a pivotal role of inter-organ aspartate metabolism for the treatment of citrin deficiency.